IMCD - IMCD N.V. (WBAG) - Share Price and News

IMCD N.V.
AT ˙ WBAG ˙ NL0010801007
€ 114,15 ↑0.05 (0.04%)
2025-07-10
SHARE PRICE
Overview
IMCD N.V. is a global leader in the sales, marketing, and distribution of specialty chemicals and ingredients, rooted in Rotterdam, the Netherlands. Since its establishment in 1995, IMCD has grown significantly through numerous strategic acquisitions and organic developments, expanding its footprint across Europe, Asia-Pacific, Africa, and the Americas. The company excels in offering innovative and comprehensive solutions across various industries such as pharmaceuticals, food and nutrition, personal care, and coatings. Through its advanced technical expertise and strong supplier partnerships, IMCD continues to propel value-added growth, focusing on sustainable and technologically advanced solutions to meet evolving market demands. This strategic focus supports IMCD's robust business model, fostering steady financial performance and reinforcing its market position in the specialty chemicals distribution sector.
AI+ Ask Fintel’s AI assistant about IMCD N.V..
Thinking about good questions…
Basic Stats

The share price of IMCD N.V. as of 10 July 2025 is € 114,15 / share. The market cap (or net worth) of IMCD N.V. as of 10 July 2025 is € 6.738,60 MM.

The Factor Analysis chart (below right) shows a view of IMCD N.V. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap 6,738.60 MM
EV 7,916.83 MM
Shares Out. 59.03 MM
Earnings Date
EPS (TTM) 4.71
Dividend Yield 3.85 %
Ex-Dividend Date 2025-04-29
Borrow Rate
Short Shares Avail.
Short Interest
Short Float
Days to Cover
Risk Free Rate 4.05 %
Price Change (1 yr)
Volatility (1 yr) 0.09
Beta 2.48
Sharpe Ratio (1 yr)
Sortino Ratio (1 yr)
PE Ratio 24.23
Price/Book 3.04
Price/TBV -17.07
Book/Market 0.33
EBIT/EV 0.05
EBIT(3yr avg)/EV 0.05
ROA 0.06
ROE 0.16
ROIC 0.07
CROIC 0.03
OCROIC 0.07
Implied Volatility
Put/Call OI Ratio
Growth
Profitability
Quality Score
Value Score
Momentum Score
Stability (Low Vol) Score 96.33 /100
Analyst Sentiment
Fund Sentiment
Insider Sentiment
Officer Sentiment
Dividend Score
QVM Score
Piotroski F-SCORE 6.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for IMCD N.V.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2023-11-27 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-11-27 HSBC Buy Buy Maintains
2023-11-24 ING FM Buy Buy Maintains
2023-11-10 DEGROOF PETERCAM Hold Hold Maintains
2023-08-28 HSBC Buy Buy Maintains
2023-08-27 HSBC Buy Buy Maintains
2023-08-25 ING FM Buy Buy Maintains
2023-08-24 ING FM Buy Buy Maintains
2023-08-23 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-08-22 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-08-04 KBC SECURITIES Buy Buy Maintains
2023-08-04 DEGROOF PETERCAM Hold Hold Maintains
2023-08-03 KBC SECURITIES Buy Buy Maintains
2023-08-03 DEGROOF PETERCAM Hold Hold Maintains
2023-05-24 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-05-23 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-05-22 HSBC Buy Buy Maintains
2023-05-21 HSBC Buy Buy Maintains
2023-05-08 ING FM Hold Buy Upgrade
2023-05-07 ING FM Hold Buy Upgrade
2023-03-27 HSBC Buy Buy Maintains
2023-03-22 BNP PARIBAS EXANE Neutral Neutral Maintains
2022-12-07 ING FM Hold Buy Upgrade
2022-11-10 BERENBERG Buy Hold Downgrade
2022-11-10 BERENBERG Hold Hold Maintains
2022-11-09 BERENBERG Hold Hold Maintains
2022-05-13 SOCIETE GENERALE Hold Hold Maintains
2022-05-12 SOCIETE GENERALE Hold Hold Maintains
2022-05-04 CREDIT SUISSE - EUROPE Neutral Underperform Downgrade
2022-05-03 CREDIT SUISSE - EUROPE Neutral Underperform Downgrade
2021-12-07 CREDIT SUISSE - EUROPE Outperform Neutral Downgrade
2021-12-06 CREDIT SUISSE - EUROPE Outperform Neutral Downgrade
2021-12-01 ING FM Hold Hold Maintains
2021-11-30 ING FM Hold Hold Maintains
2021-04-09 CREDIT SUISSE - EUROPE Outperform Outperform Maintains
2021-04-08 CREDIT SUISSE - EUROPE Outperform Outperform Maintains
2020-09-16 BERENBERG Buy Buy Maintains
2024-08-04 BNP PARIBAS EXANE Neutral Neutral Maintains
2024-08-01 ODDO BHF Buy Buy Maintains
2024-08-01 KBC SECURITIES Buy Hold Downgrade
2024-08-01 DEGROOF PETERCAM Hold Hold Maintains
2024-07-17 BERENBERG Hold Buy Upgrade
2024-05-28 ING FM Buy Buy Maintains
2024-05-26 HSBC Buy Hold Downgrade
2023-11-26 BNP PARIBAS EXANE Neutral Neutral Maintains
2023-11-26 HSBC Buy Buy Maintains
2023-11-23 ING FM Buy Buy Maintains
2023-11-09 DEGROOF PETERCAM Hold Hold Maintains
2025-01-06 BERENBERG Buy Buy Maintains
2024-12-19 ING FM Buy Buy Maintains
2024-12-02 DEGROOF PETERCAM Hold Hold Maintains
2024-11-13 BNP PARIBAS EXANE Neutral Neutral Maintains
2024-11-12 KBC SECURITIES Hold Hold Maintains
2024-11-07 ODDO BHF Buy Buy Maintains
2024-08-25 HSBC Hold Hold Maintains
2025-03-31 BERENBERG Buy Buy Maintains
2025-03-26 JEFFERIES Buy Buy Maintains
2025-03-23 HSBC Hold Buy Upgrade
2025-03-04 ODDO BHF Buy Buy Maintains
2025-03-04 KBC SECURITIES Hold Hold Maintains
2025-03-04 DEGROOF PETERCAM Hold Hold Maintains
2025-02-25 ING FM Buy Buy Maintains
2025-07-17 BERENBERG Buy Buy Maintains
2025-07-03 DEGROOF PETERCAM Hold Hold Maintains
2025-07-02 JEFFERIES Buy Buy Maintains
2025-05-27 ING FM Buy Buy Maintains
2025-05-25 HSBC Buy Buy Maintains
2025-04-24 ODDO BHF Buy Buy Maintains
Other Listings
GB:IMCDA
US:IMDZF
GB:0QVU € 92,45
DE:INX € 93,28
MX:IMCD N
NL:IMCD € 91,60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista